NPR science journalist Richard Harris talks about his book, Rigor Mortis: How Sloppy Science Creates Worthless Cures, Crushes Hope and Wastes Billions.
The surprising insight could provide foundation for future cure
Certain proteins that coordinate the healing response are present at higher levels in oral tissue—meaning wounds in the mouth fix faster. Christopher Intagliata reports.
The genetics testing company and GlaxoSmithKline are using five million people’s data to develop medical treatments
The surprising results have buoyed hopes for treatment
By analyzing the proteins in ancient dental plaque, archaeologists determined that British menus almost three millennia ago featured milk, oats and peas. Christopher Intagliata reports.
Healthcare experts seek to unpack the bold and the bluster in the varying proposals
Americans could have saved $4.5 billion last year if these products were more available, agency official says
Researchers are developing diagnostics to determine which drugs might work for specific patients
Memorial Sloan Kettering researchers are building a safer opioid
The medication can reduce the duration of symptoms
Survival was better than expected with this genetically modified pathogen
The drug will treat two rare forms of epilepsy
Many Earth-bound efforts focus on synthetic chemicals, but some researchers hope the stress of space could provide new insights
No new cases have been reported for two weeks in the Democratic Republic of the Congo
At the second Science on the Hill event, AI, Robotics and Your Health, experts from academia and the private sector talked with Scientific American Editor in Chief Mariette DiChristina about the future of AI and robotics in medicine...
Right now, each child would need to be tested prior to receiving the shot
This new cell-sorting method could offer more options in the lab and clinic
Rapid-response therapies use the lethal bug’s own speed to crowd it out of the gut
Only one experimental shot, made by Merck, has been approved for use amid the current outbreak